Clinical Trial

Neoadjuvant vs Adjuvant in Locally Advanced Recurrent NPC

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
A multicenter randomized controlled study of surgery combined with neoadjuvant and adjuvant therapy for locally advanced recurrent nasopharyngeal carcinoma in comparison to surgery combined with adjuvant therapy
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-01-23; most recent amendment 2025-05-28.
Status change: Not Yet Recruiting → Recruiting 2024-06-14
Trial Details
NCT Number NCT06235203
Lead Sponsor Eye & ENT Hospital of Fudan University
Collaborators: Shanghai Zhongshan Hospital, Shanghai 6th People's Hospital, Changhai Hospital, Fujian Medical University Union Hospital, People's Hospital of Guangxi Zhuang Autonomous Region, Shenzhen Second People's Hospital
Conditions Recurrent Nasopharyngeal Carcinoma
Enrollment 154 participants
Start Date 2024-07-09
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-06-03